Monday, December 5, 2022
New coronavirus variants made monoclonal antibody drugs ineffective
Over the last two years, the FDA authorized six monoclonal antibody treatments for Covid, but omicron's many subvariants rendered the drugs less effective so the FDA gradually revoked each of those authorizations. Bebtelovimab, made by Eli Lilly, was the last one standing...
Subscribe to:
Post Comments (Atom)
Click Older Posts above to see more.
No comments:
Post a Comment